Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirvaso and Internet Surveys for Rosacea Adherence
NCT03048058Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine transdermal lotion in rosacea, sponsored by Wake Forest University Health Sciences. Started May 2016; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03048058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048058.